Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance.

Classen D, Jaser L, Budnitz DS. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf. 2010;36(1):12-21.

Save
Print
January 13, 2010
Classen D, Jaser L, Budnitz DS. Jt Comm J Qual Patient Saf. 2010;36(1):12-21.
View more articles from the same authors.

Adverse drug events (ADEs) are the most common type of errors in hospitalized patients. This study used data from the Medicare Patient Safety Monitoring System (which conducts detailed chart reviews of hospitalized Medicare patients) to arrive at national estimates for the incidence of ADEs in the Medicare patient population. Errors were common among patients receiving high-risk medications such as warfarin, insulin, and heparin—in fact, nearly 1 in 7 patients receiving heparin experienced an ADE. Medication errors were associated with an increased length of stay, as demonstrated in prior research. A related editorial discusses the MPSMS as an example of a patient-centered approach to detecting harmful errors. A case of an error associated with insulin prescribing is discussed in an AHRQ WebM&M commentary.

Save
Print
Cite
Citation

Classen D, Jaser L, Budnitz DS. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf. 2010;36(1):12-21.

Related Resources From the Same Author(s)
Related Resources